JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment-Reference-Cited by-同舟云学术

JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment

Published:2013-09-16 Issue:4 Volume:74 Page:622-626
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Schippling Sven¹²,Kempf Christian³,Büchele Fabian²,Jelcic Ivan¹,Bozinov Oliver⁴,Bont Adriano⁵,Linnebank Michael¹²,Sospedra Mireia¹,Weller Michael²,Budka Herbert³,Martin Roland¹²

Affiliation:

1. Neuroimmunology and Multiple Sclerosis Research Section; Department of Neurology; University Hospital Zurich; Zurich

2. Department of Neurology; University Hospital Zurich; Zurich

3. Institute of Neuropathology; University Hospital Zurich; Zurich

4. Department of Neurosurgery; University Hospital Zurich; Zurich

5. Private Neurology Clinic; Winterthur Switzerland

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.23973/fullpdf

Reference21 articles.

1. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy;Padgett;Lancet,1971

2. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies;Major;Ann Rev Med,2010

3. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis;Tan;Lancet Neurol,2010

4. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis;Kleinschmidt-DeMasters;N Engl J Med,2005

5. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis;Clifford;Arch Neurol,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infektionen und Multiple Sklerose;Fortschritte der Neurologie · Psychiatrie;2024-05-08

2. Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world;Expert Opinion on Drug Safety;2023-06-10

3. Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline;Practical Neurology;2022-07-21

4. Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis;Multiple Sclerosis and Related Disorders;2021-02

5. Cerebellar syndrome in a man treated with natalizumab;Neurology - Neuroimmunology Neuroinflammation;2019-03-07